MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.
Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
StockStory.org on MSN1d
Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations SignificantlyBiotechnology company Moderna (NASDAQ:MRNA) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 65.6% year ...
Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA ...
IFLScience on MSN5d
Montana Considers Becoming First US State To Ban mRNA Vaccine UseLaura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.
How Goodhart’s Law Reveals the Opportunity in Long-Term Innovation Investing, and why traditional performance metrics may be ...
Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing ...
The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback